Encompass Health Corporation (EHC) Tops Q4 EPS by 13c; offers guidance

Encompass Health Corporation (NYSE: EHC) reported Q4 EPS of $0.95, $0.13 better than the analyst estimate of $0.82. Revenue for the quarter came in at $1.25 billion versus the consensus estimate of $1.24 billion.

GUIDANCE:

Encompass Health Corporation sees FY2024 EPS of $3.77-$4.06, versus the consensus of $3.84. Encompass Health Corporation sees FY2024 revenue of $5.2-5.3 billion, versus the consensus of $5.194 billion.

For earnings history and earnings-related data on Encompass Health Corporation (EHC) click here.

You May Also Be Interested In

• 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
• 51Talk Online Education Group (COE) Reports Q1 EPS of $0.00
• The Lovesac Company (LOVE) Tops Q1 EPS by 29c